home / stock / kod / kod news


KOD News and Press, Kodiak Sciences Inc

Stock Information

Company Name: Kodiak Sciences Inc
Stock Symbol: KOD
Market: NASDAQ
Website: kodiak.com

Menu

KOD KOD Quote KOD Short KOD News KOD Articles KOD Message Board
Get KOD Alerts

News, Short Squeeze, Breakout and More Instantly...

KOD - Tracking Baker Brothers Portfolio - Q1 2024 Update

2024-06-11 00:24:03 ET Summary Baker Brothers' 13F portfolio value decreased from $8.79B to $7.97B. The largest five stakes in the portfolio are Incyte, BeiGene, ACADIA Pharma, Madrigal Pharma, and Rhythm Pharma. Baker Brothers has had successful investments in companies that ...

KOD - Kodiak Sciences to Present at Upcoming Investor and Clinical Conferences

Kodiak Sciences to Present at Upcoming Investor and Clinical Conferences PR Newswire PALO ALTO, Calif. , May 29, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transfor...

KOD - Kodiak Sciences GAAP EPS of -$0.82 beats by $0.21

2024-05-15 17:09:42 ET More on Kodiak Sciences Kodiak Sciences Inc. (KOD) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Kodiak Sciences Historical earnings data for Kodiak Sciences Financial information for Kodiak Sciences ...

KOD - Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results

Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results PR Newswire PALO ALTO, Calif. , May 15, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and financial results for the qu...

KOD - Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy

Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy PR Newswire PALO ALTO, Calif. , May 13, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to r...

KOD - Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform

Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform PR Newswire Tarcocimab clinical and non-clinical data high...

KOD - BGC, DRS and AMTX are among after hour movers

2024-04-19 17:56:39 ET Gainers: BGC Group ( BGC ) +8% . Taboola  ( TBLA ) +5% . Lam Research Corporation ( LRCX ) +4% . Kodiak Sciences  ( KOD ) +3% . Leonardo  ( DRS ) +3% . Losers: Rani Therapeutics ...

KOD - US Companies Moving the Markets, Evening edition
Fri, Mar 29, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Nikola Corporation (NKLA) rose 14.4% to $1.04 on volume of 163,835,451 shares S&P 500 ETF TRUST ETF (SPY) fell 0.0% to $523.07 on volume of 96,294,886 shares Gamida Cell Ltd. (GMDA) fell 39.0% to $0.0361 on volume of 89,181,214 sh...

KOD - US Companies Moving the Markets, Morning edition
Fri, Mar 29, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Nikola Corporation (NKLA) rose 14.4% to $1.04 on volume of 163,835,451 shares S&P 500 ETF TRUST ETF (SPY) fell 0.0% to $523.07 on volume of 96,294,886 shares Gamida Cell Ltd. (GMDA) fell 39.0% to $0.0361 on volume of 89,181,214 sh...

KOD - Kodiak Sciences Inc. (KOD) Q4 2023 Earnings Call Transcript

2024-03-28 20:57:08 ET Kodiak Sciences Inc. (KOD) Q4 2023 Results Conference Call March 28, 2024 04:30 PM ET Company Participants John Borgeson - CFO Victor Perlroth - Chairman and CEO Pablo Velasquez Martin - SVP of Clinical Research and Development Confer...

Next 10